An ageing population, rising antimicrobial resistance, and the ongoing threat of infectious and chronic diseases are placing immense pressure on our societies. A shift to a preventative approach is necessary for the efficiency and sustainability of our healthcare systems. Central to this shift is the often-underutilized tool of life-course immunization.
Professor Martin Michaelis and Dr Mark Wass, School of Biosciences at University of Kent, explain the long and infamous history of human infection trials.
Scientists from the University of Oxford, joint with AstraZeneca, are hopeful that their vaccine, to protect against Covid-19, could be available as early as September.
President von der Leyen, Council President Charles Michel and Prime Minister of Japan Shinzō Abe, discussed the global response to the COVID-19 pandemic.
Parents of primary school starters urged to check immunisation records after Public Health England (PHE) warns that 1 in 7 five-year-olds may not be fully immunised against MMR.
A report published by the International Longevity Centre UK (ILC-UK), supported by Sanofi Pasteur, suggests that efforts to increase vaccination coverage need to present immunisation as a positive and healthy lifestyle choice.
Technology could play a major role in overcoming some of the barriers to the uptake of adult vaccinations argues a new report, “Data, bots and drones”, published by the International Longevity Centre UK (ILC).
Q fever is an emerging problem in low and middle-income countries (LMIC) and, therefore, there is a need for improved vaccines, in the view of Head of Disease Control at Moredun Research Institute.
